Literature DB >> 17679829

Prevalence of hypertension in type 2 diabetes mellitus: impact of the tightening definition of high blood pressure and association with confounding risk factors.

Emma Kabakov1, Clara Norymberg, Esther Osher, Michael Koffler, Karen Tordjman, Yona Greenman, Naftali Stern.   

Abstract

The Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure (JNC 7) has recommended a downward shift in target blood pressure to <130/80 mm Hg in diabetic patients, thus operatively setting a new threshold level for the definition of hypertension at 130/80 mm Hg. The authors performed a retrospective chart analysis of 2227 type 2 diabetes patients treated in one hospital-based and two community-based clinics in central Israel to determine the prevalence of hypertension as a function of three diagnostic threshold levels. The prevalence of hypertension in this cohort was 60.2%, 76.5%, and 85.8% at blood pressure thresholds of 140/90, 130/85, and 130/80 mm Hg respectively. Hypertension prevalence increased with age, reaching a rate of 94.4% in patients aged 80 years or more when the cutoff value of 130/80 mm Hg was used. At this cutoff, 93.3% and 86.6% of patients with a body mass index over or under 30 kg/m(2), respectively, were diagnosed with hypertension. As hypertension appears to eventually afflict the vast majority of diabetic patients, the minority of subjects not developing hypertension emerges as a unique group, which potentially deserves further in-depth study.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17679829     DOI: 10.1111/j.1559-4564.2006.05513.x

Source DB:  PubMed          Journal:  J Cardiometab Syndr        ISSN: 1559-4564


  21 in total

1.  Fighting obesity: When muscle meets fat.

Authors:  Xin Yang; Pengpeng Bi; Shihuan Kuang
Journal:  Adipocyte       Date:  2014-12-10       Impact factor: 4.534

Review 2.  Cardioprotective effects of SGLT2 inhibitors are possibly associated with normalization of the circadian rhythm of blood pressure.

Authors:  Asadur Rahman; Hirofumi Hitomi; Akira Nishiyama
Journal:  Hypertens Res       Date:  2017-01-19       Impact factor: 3.872

Review 3.  Blood pressure reduction in diabetes: lessons from ACCORD, SPRINT and EMPA-REG OUTCOME.

Authors:  Pantelis A Sarafidis; Antonios A Lazaridis; Gema Ruiz-Hurtado; Luis M Ruilope
Journal:  Nat Rev Endocrinol       Date:  2017-01-20       Impact factor: 43.330

Review 4.  Obesity in elderly subjects: in sheep's clothing perhaps, but still a wolf!

Authors:  Etty Osher; Naftali Stern
Journal:  Diabetes Care       Date:  2009-11       Impact factor: 19.112

5.  Dietary Sodium Intake in Type 2 Diabetes.

Authors:  Laura Ferreira Provenzano; Sue Stark; Ann Steenkiste; Beth Piraino; Mary Ann Sevick
Journal:  Clin Diabetes       Date:  2014-07

6.  Hypertension and Its Associated Factors Among Type 2 Diabetes Mellitus Patients at Debre Tabor General Hospital, Northwest Ethiopia.

Authors:  Yonas Akalu; Yitayeh Belsti
Journal:  Diabetes Metab Syndr Obes       Date:  2020-05-13       Impact factor: 3.168

7.  Inhibition of soluble epoxide hydrolase alleviates insulin resistance and hypertension via downregulation of SGLT2 in the mouse kidney.

Authors:  Jinlan Luo; Shuiqing Hu; Menglu Fu; Liman Luo; Yuanyuan Li; Wenhua Li; Yueting Cai; Ruolan Dong; Yan Yang; Ling Tu; Xizhen Xu
Journal:  J Biol Chem       Date:  2021-04-14       Impact factor: 5.157

8.  Reductions in Mean 24-Hour Ambulatory Blood Pressure After 6-Week Treatment With Canagliflozin in Patients With Type 2 Diabetes Mellitus and Hypertension.

Authors:  Raymond R Townsend; Israel Machin; Jimmy Ren; Angelina Trujillo; Masato Kawaguchi; Ujjwala Vijapurkar; Chandrasekharrao V Damaraju; Michael Pfeifer
Journal:  J Clin Hypertens (Greenwich)       Date:  2015-12-10       Impact factor: 3.738

Review 9.  Prompt, aggressive BP lowering in high-risk patients.

Authors:  Kenneth A Jamerson; Jan Basile
Journal:  J Clin Hypertens (Greenwich)       Date:  2008-01       Impact factor: 3.738

10.  Effect of vitamin D on insulin resistance and anthropometric parameters in Type 2 diabetes; a randomized double-blind clinical trial.

Authors:  Ramin Heshmat; Ozra Tabatabaei-Malazy; Shabnam Abbaszadeh-Ahranjani; Samimeh Shahbazi; Ghazal Khooshehchin; Fathemeh Bandarian; Bagher Larijani
Journal:  Daru       Date:  2012-08-28       Impact factor: 3.117

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.